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Transcriptional regulation of lung development:
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Abstract
The lung is the product of a set of complex developmental interactions between two distinct
tissues, the endodermally derived epithelium and the mesoderm. Each tissue contributes to
lung development by fine-tuning the spatial and temporal pattern of gene expression for a
distinct array of signaling molecules, transcriptional molecules and molecules related to the
extracellular matrix. Morphoregulatory transcriptional factors such as NKX2.1 have the
crucial role of connecting the cell–cell crosstalk to the activation or repression of gene
expression through which processes such as cellular proliferation, migration, differentiation
and apoptosis can be controlled. Although none of the factors participating in lung
development are exclusively lung-specific, their unique combinations and interactions
constitute the basis for emergence of lung structural and functional specificities. An
understanding of the individual molecules and their unique interactions in the context of lung
development is necessary for the construction of a morphogenetic map for this vital organ as
well as for the development of rational and innovative approaches to congenital and induced
lung disease.
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BMP-4 = bone morphogenetic protein-4; ECM = extracellular matrix; FGF = fibroblast growth factor; Gli = glial nuclear protein; HFH = hepatocyte
nuclear factor-3/forkhead homolog; HNF-3 = hepatocyte nuclear factor-3; P-D = proximo-distal; PDGF = platelet-derived growth factor; RAR =
retinoic acid receptor; SHH = Sonic hedgehog.
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Introduction
Temporal and spatial control of gene expression by tran-
scriptional factors is a hallmark of development. The lung is
no exception to this, and the program of lung development
from its inception is directed by the activity of key transcrip-
tional factors. The present review is a process-based rather
than a gene-based perspective on the role of morpho-
regulatory transcription factors in lung development. Refer-
ence is also made to the morphogenetic signaling
molecules that might be involved in modulating transcrip-
tional factors. Although lung development is a continuum,
for simplicity it can be viewed as occurring in four phases:
the first is the specification of the lung primordium; next
comes the formation of the trachea and septation from the
esophagus; after this is branching morphogenesis and
establishment of the infrastructure for the differentiation of
specialized epithelial cells along the proximo-distal (P-D)
axis; and finally alveologenesis and differentiation of distal
epithelial cell types, alveolar type I and type II cells, take
place (Fig. 1).Respiratory Research    Vol 1 No 2 Minoo
In general, morphoregulatory transcriptional factors consti-
tute an operational linkage between signaling and cellular
behavior, as illustrated by the simple paradigm signaling®
transcription factors®®®cellular behavior.
In the lung, signaling is mediated by peptide growth factors
such as fibroblast growth factor (FGF) and bone morpho-
genetic protein-4 (BMP-4), as well as by the morphogens
Sonic hedgehog (SHH) and retinoids. Morphogenetic sig-
naling originating from the cell’s environment is translated
into cellular behavior through changes in the activity of tran-
scription factors such as hepatocyte nuclear factor-3
(HNF-3), NKX2.1 and GATA6. Among these, the role of
NKX2.1 as a transcriptional regulator of lung development
is somewhat better understood, permitting a more detailed
discussion. By definition, transcription factors modulate the
activity of downstream target genes, so the potential
targets are presumably those encoding members of the
extracellular matrix (ECM): ECM proteins, cell–cell
receptors and cell–ECM receptors. The sum of the latter
reactions lead to changes in cell behavior (such as prolifer-
ation, migration and differentiation) that are at the heart of
morphogenesis (Fig. 2).
Phase I: specification of the lung primordium
The origin of the lung epithelium is the embryonic gut
endoderm [1], whose emergence occurs at gastrulation
from the cells within the early node and the primitive
streak. The lung mesenchyme is thought to be contributed
by the splanchnic mesenchyme and possibly the neural
crest. The lung primordium originates from the ventral wall
of the anterior foregut. Although direct information is
scarce, the accumulated data indicate that a ‘hierarchy’ of
transcriptional regulators might participate in temporal and
spatial specification of the lung primordium. The first
detectable transcriptional regulatory genes whose expres-
sion persists in endodermally derived adult structures is
the winged-helix HNF-3 gene family whose members
retain striking similarities to those of the forkhead (fkh)
gene family in Drosophila [2]. The lung primordium is
specified within the boundaries of HNF-3b and HNF-3a
expression. HNF-3a and HNF-3b are detected as early as
the time at which the esophagus and laryngo-tracheal
groove begin to differentiate (day 9.5 in mouse). HNF-3a
and HNF-3b are expressed in fully differentiated adult
bronchial epithelium [2] and participate in the regulation of
lung-specific genes such as Sp-b [which encodes surfac-
tant protein (SP) B] in vitro [3]. Another member, HNF-3g,
is detectable during hindgut differentiation and persists
through liver and stomach morphogenesis.
Thus, the regionally specific expression of HNF-3 gene
family might constitute a molecular axial code specifying
the progenitors of the structures that emerge from the gut
endoderm. Whether activation of the HNF-3 gene family is
necessary or sufficient for specification of the lung
primordium remains to be determined experimentally.
HNF-3b–/– embryos die in early fetal development before
the onset of lung morphogenesis [4]. With the exception
of a single paper [5] implicating a putative SHH-indepen-
dent glial nuclear protein (Gli) pathway, little in the way of
direct experimental evidence is available about the signals
that specify the lung primordium. In compound homo-
zygous Gli2;Gli3 mutants, no evidence of lung structure
can be ascertained [5]. Shh encodes a morphogen, phylo-
Figure 1
Four arbitrary phases in lung development and the key mediators. GR,
glucocorticoid receptor.
Figure 2
Epithelial mesenchymal interactions in lung development. Examples of
the major participants are included.c
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genetically related to hedgehog in Drosophila, which is
involved in the patterning of a number of body parts in the
fruitfly. SHH is expressed in the pulmonary epithelium and
is thought to interact with the cellular receptor patched on
mesenchymal cells. Intracellular SHH signaling is medi-
ated through the activation of the Gli family of transcrip-
tional factors, the vertebrate homologs of the Drosophila
cubitus interruptus. Three Gli transcription factors are
expressed in the lung mesenchyme in distinct temporal
and spatial patterns. The effects of Gli2;Gli3 compound
mutation seems to be independent of SHH signaling,
because Shh–/– mutant embryos are born with lung
parenchyma, albeit abnormal [6]. It is noteworthy that
specification of the lung primordium seems to be indepen-
dent of almost all factors currently deemed to be crucial to
subsequent normal lung morphogenesis (such as Nkx2.1,
Shh and Fgf-10; see below). That is, a lung rudiment,
albeit abnormal, is found in functionally null mutants of all
the aforementioned genes.
Phase II: morphogenesis and cellular
differentiation along the trachea
Concurrently with the formation of the lung bud, the
expression pattern of a homeodomain transcriptional
factor NKX2.1 (otherwise known as TTF-1 or TEBP) co-
incides with the dorso-ventral boundary within the anterior
foregut, clearly distinguishing the pulmonary primordium
from that of the esophagus [7]. Early growth and develop-
ment of the lung primordium results in the formation of the
trachea, the most proximal pulmonary structure. Little or no
information is available about the mechanisms that govern
the outgrowth of the lung primordium into a tracheal tube.
Even in the most severe experimentally induced pheno-
types of lung abnormalities — disruptions of the FGF
pathway — a tracheal tube is nevertheless formed [8,9]. In
Nkx2.1–/– lungs the trachea is markedly foreshortened and
remains fused to the esophagus, resembling a relatively
rare anatomical deformity in humans, known as ‘complete
tracheo-esophageal cleft’. Similar tracheo-esophageal
phenotypes have been described for Shh–/–,
Gli2–/–;Gli3+/– and compound retinoic acid receptor
RAR-a1–/–;RAR-b2–/– mutants [5,6,10]. Retinoid recep-
tors are members of the nuclear receptor superfamily that
mediate the effects of signaling by retinoids. The relation-
ship, if any, between retinoids, Shh and Nkx2.1 in the
process of tracheo-esophageal septation remains to be
deciphered. Shh is expressed in Nkx2.1–/– lungs; con-
versely,  Nkx2.1 can be detected in Shh–/– lungs, suggest-
ing independent but perhaps functionally parallel roles for
the two loci in tracheal morphogenesis.
In vertebrates the trachea includes a number of pheno-
typically distinct cell types, including ciliated and non-
ciliated columnar epithelial cells and many secretory
cells such as serous and goblet cells. The specific
signaling and transcriptional mediators necessary for the
differentiation and spatial organization of these cell types
along the trachea remain largely unknown. A member of
the winged-helix family of transcription factors,
HNF-3/forkhead homolog-4 (HFH-4), which is expressed
in the bronchial epithelium, seems to be necessary for the
differentiation of ciliated epithelial cells in the lung [11].
Hfh-4 is not specific to the lung; its expression occurs in
fetal kidney, oviduct and other embryonic organs. Thus,
the entire process of ciliogenesis is absent from Hfh-4–/–
embryos that also exhibit situs abnormalities [11]. Hfh-4
seems to be not only necessary but also sufficient for the
differentiation of columnar ciliated epithelial cells because
ectopic expression of Hfh-4 results in the appearance of a
subset of columnar cells in the distal lung, where cuboidal
type II and squamous type I epithelial cells normally
abound exclusively [12].
Phase III: branching morphogenesis and
development of the lung parenchyma
Lung development and the differentiation of highly special-
ized cell types along the P-D axis require branching
morphogenesis. Branching morphogenesis is dependent
on epithelial–mesenchymal interactions through the activity
of a complex network of molecules including peptide
growth factors, transcriptional regulators and ECM
proteins and their receptors [13]. In general, the nature of
the interactions between the epithelial and mesenchymal
compartments is based on the exchange of developmental
cues that establish positional information at the level of
individual cells. Depending on their developmental history,
the cells base their behavior, whether it be proliferation,
migration or differentiation, on the interpretation of the
available positional information within a given morpho-
genetic boundary [14•]. In the simplest model, develop-
mental signals necessary for morphogenesis and
cytodifferentiation can be communicated as positional
information through cell–cell interactions that trigger
specific patterns of gene expression by the activation of
transcriptional regulators.
Currently, the crucial components of epithelial–
mesenchymal interactions include a number of signaling
molecules and transcription factors (Fig. 2). In the lung
epithelium, among a number of major signaling molecules
with established roles are BMP-4, SHH and platelet-
derived growth factor (PDGF), although BMP-4 is also
detectable in the mesenchyme late in embryonic lung
development. In the lung mesenchyme, the most crucial
mediator of branching morphogenesis is the FGF
pathway and in particular FGF-10. In addition to the Gli
family,  Hox cluster transcription factors are also
expressed in the lung mesenchyme. The transcription
factors HNF-3, HFH-4, GATA6, N-Myc and NKX2.1 are
expressed in the lung epithelium and although the evi-
dence for HNF-3 and GATA6 is indirect, they all seem to
be key regulators of epithelial–mesenchymal interactions.Transcriptional regulators and signaling in the lung
mesenchyme
Although the role of mesenchyme in lung morphogenesis
has been appreciated for a long time, the genetic dissec-
tion of mesenchyme has proved far more difficult. Classi-
cal and more recent, elegant experiments with tissue
recombination have clearly shown that two functionally
distinct types of mesenchyme direct tracheal (non-
branching) and parenchymal (branching) lung epithelial
morphogenesis [15]. The signaling and the transcrip-
tional factors expressed by the two mesenchyme types
are presumed to be distinct, but few discrete data are
currently at hand. Members of the transcriptional factors
encoded by the Hox superfamily are known to be
expressed in the lung mesenchyme. In particular, target-
ing of the Hoxa-5 gene reveals the crucial role of this
family in directing epithelial morphogenesis. Hoxa-5–/–
mice die postnatally of abnormalities associated with
morphogenesis of the trachea and decreased pulmonary
surfactant production (cell differentiation) in the lung,
and abnormal expression of epithelial transcription
factors  Nkx2.1,  Hnf-3 and  Myc [16]. Because transcrip-
tion factors are by definition unlikely to mediate cell–cell
interactions directly, potential downstream target(s) of
Hoxa-5 must include signaling factors (such as FGFs)
and ECM components and their receptors.
Another key mesenchymal mediator of lung development
is the FGF signaling pathway. Disruption of this pathway
leads to profound interruptions in lung morphogenesis.
FGFs are made by the mesenchyme but act through
their cognate receptors found on epithelial cells.
Targeted disruption of Fgf-10 results in a lack of lung
structures distal to mainstem bronchi [8,9]. The role of
FGF in directing epithelial morphogenesis is probably
related to its ability to direct both epithelial cell prolifera-
tion and cell differentiation. Transcriptional factors
activated by FGF-induced cell proliferation, such as c-fos
and c-myc, have been identified and probably have
similar role(s) in the proliferation of lung epithelial and
mesenchymal cells. Morphoregulatory transcription
factors activated in the lung by FGF-10 remain elusive. In
limb morphogenesis, ectopic application of FGF leads to
the activation of SnR, which encodes a vertebrate
homolog of the Drosophila zinc-finger transcription
factor  Snail [17]. Other transcription factors, in particu-
lar Tbx-4 and Tbx-5, are also activated in response to
FGF signaling in early limb specification. Members of
the Tbx family of transcription factors are expressed in
the lung epithelium [18] but their relationship to FGF
signaling has not been explored. An examination of
whether and how any of the latter transcriptional regula-
tors are involved in epithelial–mesenchymal interactions
during lung development is needed to elucidate the key
role of the FGF signaling pathway in driving lung
morphogenesis.
Transcriptional regulators and signaling in the lung
epithelium; P-D morphogenesis
Throughout lung development, cell–cell interactions
between the epithelial and the mesenchymal compartments
of the lung are vital for normal morphogenesis. Presumably,
transcriptional factors mediate the instructive and inductive
signaling that arises from cell–cell interactions. For example,
during lung branching morphogenesis, the reception and/or
interpretation of mesenchymal signaling by epithelial cells
are dependent on, among others, the normal activity of the
N-myc locus. N-myc is expressed in the lung epithelium,
and mouse embryos with targeted disruption of N-myc
develop abnormal dysfunctional lungs [19]. The N-myc
proto-oncogene encodes a basic helix–loop–helix leucine
zipper transcription factor that is thought to be involved in
both cellular proliferation and differentiation.
Important outcomes of cell–cell interactions are the spatial
organization of the lung along the P-D axis and the differ-
entiation of specialized epithelial cell types. The most pro-
found disruption of lung growth and differentiation along
the P-D axis occurs in Fgf-10–/– mutant embryos (see
above). In mutations that allow the progression of lung
beyond the mainstem bronchi, disruption of Nkx2.1
renders the most severe defects in P-D morphogenesis. In
Nkx2.1–/– embryos, no evidence of distal lung structure
beyond the secondary or tertiary bronchi exists [7]. The
disruption of SHH signaling also perturbs P-D lung mor-
phogenesis. Nevertheless, limited distal lung development
and cellular differentiation are observed because cells
expressing surfactant proteins can indeed be detected in
Shh–/– lungs [6]. Thus, lung development can be viewed
as a two-step process. Proximal lung morphogenesis is
independent of Nkx2.1, Fgf-10 and Shh, whereas distal
lung morphogenesis is strictly dependent on Nkx2.1 and
Fgf-10 (and somewhat dependent on Shh).
NKX2.1 is a homeodomain transcriptional regulator that is
expressed in the lung, the thyroid and the ventral forebrain.
In co-transfection experiments, Nkx2.1 activates the pro-
moters of lung-specific surfactant protein genes such as
Sp-b [3]. NKX2.1 was the first homeodomain transcrip-
tional regulator whose suppression by antisense oligonu-
cleotides [20] or disruption by homologous recombination
in vivo [21] resulted in severely abnormal lungs, leading to
postnatal death due to respiratory failure. Several lines of
evidence suggest that an absence of Nkx2.1 activity leads
to the inhibition of distal lung morphogenesis [22].
Morphologically,  Nkx2.1–/– lung epithelium is composed
solely of stratified and pseudostratified columnar epithelial
cells, which are characteristically found in proximal com-
partments of wild type lungs. The absence of distal lung
epithelial-specific differentiation markers (for example Sp-c
and Sp-a), combined with evidence of ciliary differentiation
and the synthesis of acid mucopolysaccharides, which are
found in differentiated tracheal and bronchial epithelia,
Respiratory Research    Vol 1 No 2 Minoofurther suggest that Nkx2.1–/– lungs are arrested in a prox-
imal state. Importantly, the expression pattern of regionally
specific, differentially spliced forms of vascular endothelial
growth factor (Vegf) transcripts is uniquely proximal in
Nkx2.1–/– lungs, providing further evidence that lung distal
morphogenesis is inhibited in the absence of Nkx2.1 [22].
Given the profound abnormalities in Nkx2.1–/– lungs, it is
important to know the downstream targets and upstream
modulators of this critical transcriptional regulator. The
expression of Bmp4, a-integrins and collagen type IV are
reduced or absent in Nkx2.1–/– lungs, suggesting that
they might be downstream of Nkx2.1 [22]. Bmp4 is a
major participant in lung distal morphogenesis whose
expression is confined to the growing tip of the branching
epithelium. The targeted disruption of Bmp4 resulted in
embryonic lethality before embryonic day 10 and was
therefore uninformative for lung morphogenesis [23]. The
operational connection between distal lung morphogene-
sis and Bmp4 was also elegantly demonstrated by the
ectopic expression of X-noggin, an inhibitor of BMP4, and
a dominant-negative BMP4 receptor, Alk-6, both of which
resulted in a proximalization of the lung akin to the func-
tional deletion of Nkx2.1 [24,25].
The precise role of Bmp4 in P-D lung morphogenesis and
its relationship with Nkx2.1 requires further study. Down-
stream of BMP-type I receptor, the transcription factors
Smad1, Smad5 and Smad8 are activated by phosphoryla-
tion, which enables them to form hetero-oligomeric com-
plexes with Smad4 and translocate to the nucleus to
mediate the transcription of Bmp4 inducible genes.
Homozygous functional deletion of Smad4 results in early
embryonic lethality before embryonic day 7.5 [26].
Smad5–/– embryos die between embryonic days 9.5 and
11.5, but lung abnormalities were not reported for these
embryos [27]. Smad3 knockout animals are viable [28]. A
family of homeodomain transcription factors encoded by
Dlx genes, which represent the vertebrate homologs of
Distalless in Drosophila are involved in P-D axis formation
and might be activated by Bmp4 signaling [29]. At least
six members of the Dlx family are expressed in neural
tissue, bone and cartilage [30]. Interestingly, the pattern of
Nkx2.1 and those of Dlx-1 and Dlx-2 overlap in the brain
[31]. Dlx-2 is expressed in the murine lung, but its precise
function remains unknown at present (C Li and P Minoo,
unpublished data).
Modulators of Nkx2.1 have proved more difficult to iden-
tify. It is not at all clear how Nkx2.1 becomes activated in
the ventral endoderm of the anterior foregut, the site of
emergence of the lung diverticulum. However, this initial
activation does not seem to be dependent on Shh [6] or
Fgf-10 signaling (P Minoo, unpublished data). In the dien-
cephalon, another site of Nkx2.1 expression, Nkx2.1 is
activated at the three-somite stage by mechanisms that
require cell–cell interactions [32]. Several studies have
been directed at deciphering the regulation of Nkx2.1 in
cell culture experiments. These studies have been con-
founded by the complexity of the Nkx2.1 gene structure
and the presence of multiple putative promoter regions. In
cell culture, HNF-3 can bind to and increase the activity of
the  Nkx2.1 promoter [33]. However, whether HNF-3 is
necessary for the activation of Nkx2.1 in vivo in the lung
primordium remains to be elucidated.
Also of interest is the possible role of members of the zinc-
finger transcription factor GATA, whose consensus
binding sites are present on Nkx2.1. GATA5 and GATA6
are expressed in the lung, but the expression of GATA6
coincides with Nkx2.1 and persists in adult alveolar type II
cells [34]. Disruption of the GATA6 locus in mice leads to
early embryonic lethality before the emergence of the lung
primordium [35]. In addition, in GATA6–/–;wild-type
chimeras no contributions have been observed of
‘green–blue’ cells of GATA6–/––lacZ genotype to pul-
monary epithelium, indicating that GATA6 has a crucial
role in pulmonary epithelial cell lineages [35]. Because in
cultured cells GATA6 participates in Nkx2.1 transcription
[34], it might also be part of the mechanism in vivo that ini-
tiates the transcription of Nkx2.1 in the ventral endoderm.
Because the 5¢ regulatory regions of Nkx2.1 contain func-
tional NKX2.1 binding sites, it is also possible that, once
activated, autoregulation might be a mechanism by which
Nkx2.1 expression is maintained in various cell types.
Phase IV: alveologenesis and differentiation
of alveolar type I and type II cells
From a physiological standpoint, alveologenesis, the
process that subdivides the lung saccular compartments
into distinct alveoli, is a key step in the maturation of the
pulmonary system and the establishment of effective gas
exchange. FGF and PDGF signaling pathways have been
implicated in alveologenesis [36,37], but transcription
factors downstream of these pathways remain unknown
(see also above). Thus, limited discrete information is
available about the signaling mechanisms and the tran-
scriptional factors that participate in alveologenesis. It is
reasonable to speculate on a role for many of the factors
involved in early lung morphogenesis whose expression
persist in the mature lung. These include Hnf-3, GATA6
and Nkx2.1. Direct demonstration for their involvement
awaits the generation of conditional mutants.
Retinoids and glucocorticoids affect alveologenesis, but
their explicit role(s) remain controversial. Retinoids are
known to alter the expression pattern of the transcriptional
factors belonging to the Hox gene cluster in the mes-
enchyme of the developing lung [38]. Such changes have
the potential to alter the inductive or instructive role of the
mesenchyme, thereby affecting epithelial morphogenesis.
However, with the exception of Hoxa-5, neither ectopic
http://respiratory-research.com/content/1/2/109
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Hox genes results in grossly abnormal lung phenotypes,
perhaps owing to functional redundancy. The role of
glucocorticoids is also not well understood. The gluco-
corticoid receptor is a transcription factor belonging to the
same superfamily as retinoid receptors. Functional dele-
tion of the glucocorticoid receptor results in postnatal
death due to respiratory insufficiency [39]. Detailed
studies have demonstrated the presence of functional glu-
cocorticoid binding sites on pulmonary surfactant protein
genes [40]. However, embryos with mutations in the DNA
binding domain of the glucocorticoid receptor that abro-
gate its dimerization and hence its gene activation capabil-
ity have normal lungs, suggesting that the effect of
glucocorticoids on lung development might not be depen-
dent on the DNA binding and transactivation of down-
stream target genes [41].
The cell lineage history of alveolar type I and type II cells is
unknown. Among a number of biochemical and morpho-
logical criteria, alveolar type II cells are defined by the syn-
thesis of surfactant protein genes whose transcription is
dependent on (or at least affected by) Nkx2.1. The pattern
of expression of Nkx2.1 during lung development sug-
gests that Nkx2.1 is selectively repressed in a P-D direc-
tion. Thus, although Nkx2.1 is expressed in nearly all
epithelial cells in early lung development, tracheal and
bronchial epithelial cells gradually lose Nkx2.1 expression
as distal lung morphogenesis ensues [22]. In parallel,
Nkx2.1 expression is selectively maintained in a subset of
cells that seem to constitute the progenitor of alveolar
type II cells. The developmental mechanism(s) involved in
the latter processes are unknown, but probably involve
cell–cell interactions. Recent results suggest that Nkx2.1
is auto-regulated (P Minoo, unpublished data). A positive
feedback loop as represented by autoregulation might
explain the mechanism by which Nkx2.1 activity is main-
tained in specific epithelial cell types during lung morpho-
genesis and in adult lung alveolar type II cells. Conversely,
abrogation of this loop might explain the mechanism by
which the selective repression of Nkx2.1 is accomplished
in a P-D direction. The transcriptional regulation of alveolar
type I cell differentiation remains entirely unknown.
Conclusions
The functional linkage between morphogenetic signaling
and cellular behavior is provided by the activity of transcrip-
tion factors. In the lung, the two compartments of meso-
derm and endodermally derived epithelium, each with
distinct sets of signaling molecules and transcription
factors, interact to implement the highly complex pattern of
structural growth of the lungs and the differentiation of
specialized epithelial cell types. In deciphering the details of
lung development, valuable insights have been gained from
studies of the transgenic manipulation of specific genes.
These studies have also provided intriguing clues to
potential overlap and interactions between various morpho-
regulatory molecules that participate in lung development
(for examples see Shh, RAR, Gli and Nkx2.1 in tracheal
development). A number of key components in lung devel-
opment are also crucial to early embryogenesis and their
disruption has led to embryonic lethality preceding lung
development. The application of conditional mutagenesis
will undoubtedly overcome this obstacle in the near future.
Perhaps the most intriguing outcome of the past few years
is the recognition that neither the signaling nor the tran-
scriptional factors are uniquely lung-specific, indicating
that lung specificity must arise from the unique combinato-
rial interactions of non-specific components. Among
these, the role of the transcriptional regulator NKX2.1 is
central to lung development. Although expressed in the
thyroid and brain, the unique response of NKX2.1 to sig-
naling molecules and its unique interactions with other
transcription factors on morphoregulatory as well as lung-
specific genes must in part underlie the specificity of
normal lung morphogenesis.
Acknowledgements
I am indebted to Phil Ballard and Franco Demayo for criticisms of the manu-
script and for making valuable suggestions. I ask forgiveness from colleagues
whose work I might have overlooked. I am grateful for the support provided by
NIH HL56590, HL60231 and the Hastings Foundation.
References
Articles of particular interest have been highlighted as:
• of special interest
•• of outstanding interest
1. Ten Have-Opbroek AAW: The development of the lung in
mammals: an analysis of concepts and findings. Am J Anat 1981,
162:201–219.
2. Monaghan AP, Kaestner KH, Grau E, Schutz G: Postimplantation
expression patterns indicate a role for the mouse forkhead/HNF-
3a a, b b and g g genes in determination of the definitive endoderm,
chordamesoderm and neuroectoderm. Development 1993, 119:
567–578.
3. Bohinski RJ, Di Lauro R, Whitsett JA: The lung-specific surfactant
protein B gene promoter is a target for thyroid transcription factor
1 and hepatocyte nuclear factor 3, indicating common factors for
organ-specific gene expression along the foregut axis. Mol Cell
Biol 1994, 9:5671–5681.
4. Ang SL, Rossant J: HNF-3b b is essential for node and notochord
formation in mouse development. Cell 1994, 78:561–574.
5. Motoyama J, Liu J, Mo R, Ding Q, Post M, Hui CC: Essential function
of Gli2 and Gli3 in the formation of lung, trachea and esophagus.
Nat Genet 1998, 20:54–57.
6. Pepicelli CV, Lewis ML, McMahon P: Sonic hedgehog regulates
branching morphogenesis in the mammalian lung. Curr Biol 1998,
8:1083–1086.
7. Minoo P, Su G, Drum H, Bringas P, Kimura S: Defects in tra-
cheosophageal and lung morphogenesis in Nkx2.1(- -/- -) mouse
embryos. Dev Biol 1999, 209:60–71.
8. Min H, Danielko DM, Scully SA, Bolon B, Rihg BD, Tarpley JE, DeRose
M, Simonet WS: Fgf-10 is required for both limb and lung develop-
ment and exhibits striking functional similarity to Drosophila
branchless. Genes Dev 1998, 12:3156–3161.
Respiratory Research    Vol 1 No 2 Minoo9. Sekine K, Ohuchi H, Fujiwara M, Yamasaki M, Yoshizawa T, Sato T,
Yagishita N, Matsui D, Koga Y, Itoh N, Kato S: Fgf10 is essential for
limb and lung formation. Nat Genet 1999, 21:138–141.
10. Mendelsohn C, Lohnes D, Decimo D, Lufkin T, LeMeur M, Chambon P,
Mark M: Function of the retinoic acid receptors (RARs) during
development (II). Multiple abnormalities at various stages of
organogenesis in RAR double mutants. Development 1994, 120:
2749–2771.
11. Chen J, Knowles HJ, Hebert JL, Hackett BP: Mutation of the mouse
hepatocyte nuclear factor/forkhead homologue 4 gene results in
absence of cilia and random left-right asymmetry. J Clin Invest
1998,  102:1077–1082.
12. Tichelaar JW, Lim L, Costa RH, Whitsett JA: HNF-3/forkhead homo-
logue-4 influences lung morphogenesis and respiratory epithelial
cell differentiation in vivo. Dev Biol 1999, 213:405–417.
13. Minoo P, King RJ: Epithelial–mesenchymal interactions in lung
development. Annu Rev Physiol 1994, 56: 13–45.
14. Wolpert L: One hundred years of positional information. Trends 
• Genet 1996, 12:359–364.
This review and the references therein provide an extremely useful discus-
sion on the concept of positional information.
15. Shannon JM, Nielsen LD, Gebb SA, Randell SH: Mesenchyme speci-
fies epithelial differentiation in reciprocal recombinants of embry-
onic lung and trachea. Dev Dyn 1998, 212:484–494.
16. Aubin J, Lemieux M, Tremblay M, Berard J, Jeannotte L: Early postna-
tal lethality in Hoxa-5 mutant mice is attributable to respiratory
tract defects. Dev Biol 1997, 192:432–445.
17. Issac A, Cohn MJ, Ashby P, Ataliotis P, Spicer DB, Cooke J, Tickle C:
FGF and genes encoding transcription factors in early limb speci-
fication. Mech Dev 2000, 93:41–48.
18. Campbell C, Goodrich K, Casey G, Beatty B: Cloning and mapping
of a human gene (TBX2) sharing a highly conserved protein motif
with the Drosophila omb gene. Genomics 1995, 28:255–260.
19. Stanton BR, Perkins AS, Tessarollo L, Sassoon DA, Parada LF: Loss
of N-myc results in embryonic lethality and failure of the epithelial
component of the embryo to develop. Genes Dev 1992, 6:2235–
2247.
20. Minoo P, Hamdan H, Bu D, Warburton D, Stepanik P, deLemos R:
TTF-1 regulates lung epithelial morphogenesis. Dev Biol 1995,
172:694–698.
21. Kimura S, Hara Y, Pineau T, Fernandez-Salguero P, Fox HC, Ward JM,
Gonzalez FJ: The T/ebp null mouse: thyroid-specific enhancer-
binding protein is essential for the organogenesis of the thyroid,
lung, ventral forebrain, and pituitary. Genes Dev 1996, 10:60–69.
22. Yuan B, Li C, Kimura S, Engelhardt R, Smith B, Minoo P: Inhibition of
distal lung morphogenesis in Nkx2.1(- -/- -) embryos. Dev Dyn
2000,  217:180–190.
23. Lawson KA, Dunn NR, Roelen BA, Zeinstra LM, Davis AM, Wright CV,
Korving JP, Hogan BLM: Bmp4 is required for the generation of pri-
mordial germ cells in the mouse embryo. Genes Dev 1999, 13:
424–436.
24. Bellusci S, Henderson R, Winnier G, Oikawa T, Hogan B: Evidence
from normal expression and targeted misexpression that bone
morphogenetic protein-4 (Bmp-4) plays a role in mouse embry-
onic lung morphogenesis. Development 1996, 122, 1693–1702.
25. Weaver M, Yingling JM, Dunn NR, Bellusci S, Hogan BLM: Bmp sig-
naling regulates proximal–distal differentiation of endoderm in
mouse lung development. Development 1999, 126:4005–4015.
26. Sirard C, dela Pompa JL, Elia A, Itie A, Mirtsos C, Cheung A, Hahn S,
Wakeham A, Schwartz L, Kern SE, Rossant J, Mak TW: The tumor
suppressor gene Smad4/Dpc4 is required for gastrulation and
later for anterior development of the mouse embryo. Genes Dev
1998, 12:107–119.
27. Chang H, Huylebroeck D, Verschueren K, Guo Q, Matzuk MM:
Smad5 knockout mice die at mid-gestation due to multiple
embryonic and extraembryonic defects. Development 1999, 126:
1631–1642.
28. Zhu Y, Richardson JA, Parada LF, Graff JM: Smad3 mutant mice
develop metastatic colorectal cancer. Cell 1998, 94:703–714.
29. Bei M, Maas R: FGFs and BMP4 induce both Msx1-independent
and Msx1-dependent signaling pathways in early tooth develop-
ment. Development 1998, 125:4325–4333.
30. Acampora D, Merlo GR, Paleari L, Zerega B, Postiglione MP, Mantero
S, Bober E, Barbieri O, Simeone A, Levi G: Craniofacial, vestibular
and bone defects in mice lacking the Distal-less-related gene
Dlx5. Development 1999,  126:3795–3809.
31. Bulfone A, Puelles L, Porteus MH, Frohman MA, Martin GR, Ruben-
stein JLR: spatially restricted expression of Dlx-1, Dlx-2 (Tes-1)
Gbx-2, and Wnt-3 in the embryonic day 12.5 mouse forebrain
defines potential transverse and longitudinal segmental bound-
aries. J Neurosci 1993, 13:3155–3172.
32. Shimamura K, Rubenstein JL: Inductive interactions direct early
regionalization of the mouse forebrain. Development 1997, 124:
2709–2718.
33. Ikeda K, Shaw-White JR, Wert SE, Whitsett JA: Hepatocyte nuclear
factor 3 activates transcription of thyroid transcription factor 1 in
respiratory epithelial cells. Mol Cell Biol 1996, 16:3626–3636.
34. Shaw-White JR, Bruno MD, Whitsett JA: GATA-6 activates transcrip-
tion of thyroid transcription factor-1. J Biol Chem 1999, 274:2658–
2664.
35. Morrisey E, Tang Z, Sigrist K, Lu M, Jiang F, Hon S, Parmacek M:
GATA6 regulates HNF4 and is required for differentiation of visceral
endoderm in the mouse embryo. Genes Dev 1998, 12:3579–3590.
36. Weinstein M, Xu X, Ohyama K, Deng CX: FGFR-3 and FGFR-4 func-
tion cooperatively to direct alveogenesis in the murine lung.
Development 1998,  125:3615–3623.
37. Bostrom H, Willetts K, Penky M, Leyeen P, Lindhal P, Hedstrand H,
Penka M, Hellstrom M, Gebre-Medhin S, Schalling M, Nilsson M,
Kurland S, Tornell J, Heath JK, Betsholtz C: PDGF-A signaling is a
critical event in lung alveolar myofibroblast development and
alveogenesis. Cell 1996,  85:863–873.
38. Cardoso WV, Mitsialis SA, Brody JS, Williams MC: Retinoic acid
alters the expression of pattern-related genes in the developing
rat lung. Dev Dyn 1996, 207:47–59.
39. Cole TJ, Blendy JA, Monaghan P, Kriegelstein K, Schmid W, Aguzzi G,
Hummler E, Unsicker K, Schutz G: Targeted disruption of the gluco-
corticoid receptor gene blocks adrenergic chromaffin cell devel-
opment and severely retards lung maturation. Genes Dev 1995, 9:
1608–1621.
40. Ballard PL, Ertsey R, Gonzales LW, Gonzales J: Transcriptional regu-
lation of human pulmonary surfactant proteins SP-B and SP-C by
glucocorticoids. Am J Respir Cell Mol Biol 1996, 14:599–607.
41. Reichardt HM, Kaestner KH, Tuchermann J, Kretz O, Wessely O, Bock
R, Gass P, Schmid W, Herrlich P, Angel P, Schutz G: DNA binding of
the glucocorticoid receptor is not essential for survival. Cell 1998,
93:531–541.
Author’s affiliation: Department of Pediatrics, Women’s and Chil-
dren’s Hospital, University of Southern California School of Medicine,
Los Angeles, California, USA
Correspondence: Parviz Minoo, Department of Pediatrics, Women’s
and Children’s Hospital, University of Southern California School of
Medicine, Los Angeles, CA 90033, USA. Tel: +1 323 226 4340; 
fax: +1 323 226 5049; e-mail: minoo@hsc.usc.edu
http://respiratory-research.com/content/1/2/109
c
o
m
m
e
n
t
a
r
y
r
e
v
i
e
w
r
e
p
o
r
t
s
p
r
i
m
a
r
y
 
r
e
s
e
a
r
c
h